Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-859-5 | CAS number: 64381-99-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats and mice for the test chemical. The LD50 value is >5000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data from various test chemicals
- Justification for type of information:
- Data is summarized based on the available information from various read across test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on 2 acute oral toxicity studies as - WoE 2 and WoE 3
Acute Oral toxicity test was carried out to study the effects of the test chemicals on rodents. - GLP compliance:
- not specified
- Test type:
- other: Acute oral toxicity
- Limit test:
- yes
- Specific details on test material used for the study:
- No data available
- Species:
- other: 2. Rat 3. Mice
- Strain:
- other: 2. Sprague-Dawley 3.Not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- 2.TEST ANIMALS
- Source:
No data
- Females (if applicable) nulliparous and non-pregnant: [yes/no]
No data
- Age at study initiation:
No data
- Weight at study initiation:
No data
- Fasting period before study:
No data
- Housing:
No data
- Diet (e.g. ad libitum):
Rat pellets
- Water :
Distilled water ad libitum
- Acclimation period:
No data
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
No data
- Humidity (%):
No data
- Air changes (per hr):
No data
- Photoperiod (hrs dark / hrs light):
No data
IN-LIFE DATES: From: To:No data
3.Not specified - Route of administration:
- other: 2. Oral gavage 3.Not specified
- Vehicle:
- not specified
- Details on oral exposure:
- 2.Maximum dose volume applied: 5000 mg/kg bw
3.Not specified - Doses:
- 2.5000 mg/kg bw
3.10300 mg/kg bw - No. of animals per sex per dose:
- 2.5000 mg/kg bw: 10 rats
Control: 10 rats
3.Not specified - Control animals:
- yes
- Details on study design:
- 2.- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were examined after 2 hours and daily for 14 days.
- Necropsy of survivors performed: no
- Other examinations performed: clinical signs, body weight
3.No data available - Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Mortality observed
- Remarks:
- 2
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 10 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50% mortality observed
- Remarks:
- 3
- Mortality:
- 2.Death was observed in one animal at 48 hours and in a second animal at 72 hours.
3.50% mortality was observed in treated mice at dose 10300 mg/kg bw - Clinical signs:
- other: 2.All animals exhibited a mild to moderate lethargic response accompanied with ataxia, dyspnea, abnormal righting reflex, muscular weakness, piloerection and diarrhea. This condition persisted for approximately seventy-two (72) hours. 3.No data available
- Gross pathology:
- 2.Gross pathology of survivors revealed that all target organs (heart. lungs, spleen. kidneys, liver and gastro-intestinal tract) appeared normal with the exception of a mild renal vascularization.
3.No data available - Other findings:
- 2.Autopsies of expired animals revealed hyperemic lungs, nephritic kidneys, peripheral lobular hemorrhage of the liver and hemorrhagic gastro-intestinal tract.
3.No data available - Interpretation of results:
- other: Not classified
- Conclusions:
- In a acute oral toxicity study, the LD50 value was considered to be >5000 mg/kg bw when test animals were treated with test chemical.
- Executive summary:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and mice for test chemical. The studies are summarized as below –
The acute oral toxicity study was performed on rats to determine the toxic nature of the test chemical. 10 Sprague-Dawley rats were treated with test chemical at a concentration of 5000 mg/kg bw by oral intubation route. All animals exhibited a mild to moderate lethargic response accompanied with ataxia, dyspnea, abnormal righting reflex, muscular weakness, piloerection and diarrhea. This condition persisted for approximately seventy-two (72) hours. The average weight gain of the surviving test animals was 67.3 grams and that of control animals was 70.4 grams and the average weight loss of expired test animals was 19.0 grams. Gross pathology of survivors revealed that all target organs (heart. lungs, spleen, kidneys, liver and gastro-intestinal tract) appeared normal with the exception of a mild renal vascularization. Death was observed in one animal at 48 hours and in a second animal at 72 hours. Autopsies of expired animals revealed hyperemic lungs, nephritic kidneys, and peripheral lobular hemorrhage of the liver and hemorrhagic gastro-intestinal tract. Therefore based on the above observations, LD50 was considered to be >5000 mg/kg bw when 10 Sprague-Dawley rats were treated with test chemical orally.
In another acute oral toxicity study,mice were treated with test chemical at a concentration of 10300 mg/kg bw orally. No mortality was observed in treated mice. Therefore,LD50 was considered to be10300 mg/kg bw when mice were treated with test chemical orally.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >5000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimish 2 and from authoritative database
Additional information
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and mice for test chemical. The studies are summarized as below –
The acute oral toxicity study was performed on rats to determine the toxic nature of the test chemical. 10 Sprague-Dawley rats were treated with test chemical at a concentration of 5000 mg/kg bw by oral intubation route. All animals exhibited a mild to moderate lethargic response accompanied with ataxia, dyspnea, abnormal righting reflex, muscular weakness, piloerection and diarrhea. This condition persisted for approximately seventy-two (72) hours. The average weight gain of the surviving test animals was 67.3 grams and that of control animals was 70.4 grams and the average weight loss of expired test animals was 19.0 grams. Gross pathology of survivors revealed that all target organs (heart. lungs, spleen, kidneys, liver and gastro-intestinal tract) appeared normal with the exception of a mild renal vascularization. Death was observed in one animal at 48 hours and in a second animal at 72 hours. Autopsies of expired animals revealed hyperemic lungs, nephritic kidneys, and peripheral lobular hemorrhage of the liver and hemorrhagic gastro-intestinal tract. Therefore based on the above observations, LD50 was considered to be >5000 mg/kg bw when 10 Sprague-Dawley rats were treated with test chemical orally.
In another acute oral toxicity study,mice were treated with test chemical at a concentration of 10300 mg/kg bw orally. No mortality was observed in treated mice. Therefore,LD50 was considered to be10300 mg/kg bw when mice were treated with test chemical orally.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >5000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is >5000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute oral toxicity and comes under "Not Classified" category.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.